Processa amends Yuhan license; annual meeting adjourned for lack of quorum

Processa Pharmaceuticals, Inc.

Amendment No. 1 to License Agreement with Yuhan Corporation effective June 11, 2025, linked to term sheet with Intact Therapeutics dated June 17, 2025.
Annual meeting on June 30, 2025 adjourned due to insufficient quorum; reconvened for July 30, 2025 at 1:00 PM in Hanover, MD.
Record date remains May 1, 2025; previously submitted proxies and votes remain valid without further action.
No financial or operational details of the Yuhan amendment or Intact Therapeutics term sheet were disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.